<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="oil1000/PMC6520976/results/search/disease/results.xml">
  <result pre="range of diseases, including inflammatory bowel diseases (IBDs) [ 5]," exact="cancer" post="[ 6], neuropsychiatric disorders [ 7] and cardiometabolic diseases,"/>
  <result pre="7] and cardiometabolic diseases, including obesity, type 2 diabetes and" exact="cardiovascular disease" post="[ 8]. These diseases tend to inflict those living"/>
  <result pre="experiencing or who have experienced Helicobacter pylori infection can cause" exact="malabsorption" post="and bacterial overgrowth in the small intestine [ 50,"/>
  <result pre="brain-gut-microbiome communication have been implicated in various disease states, from" exact="irritable bowel syndrome" post="to psychiatric and neurologic disorders, and this is an"/>
  <result pre="from the gut microbiota has also been shown to reduce" exact="cancer" post="cell proliferation in the liver [ 89]. The SCFAs"/>
  <result pre="gut microbiota in a rodent model was shown to promote" exact="metabolic syndrome" post="[ 97]. The gut microbiota is also responsible for"/>
  <result pre="correlated with brain signatures associated with depression in patients with" exact="major depressive disorder." post="Bacterially-produced GABA is generated by the enzyme glutamate decarboxylase"/>
  <result pre="neuron activity in a rat faecal retention model of visceral" exact="hypersensitivity" post="revealing that bacterially-produced GABA can modulate abdominal pain ["/>
  <result pre="The tryptophan-metabolising strain Peptostreptococcus russellii provided a protective effect against" exact="colitis" post="in mice, which the authors suggest is linked to"/>
  <result pre="properties, decreasing activation of the NF-κB pathway and also prevented" exact="colitis" post="in an animal model [ 150]. M-cells are specific"/>
  <result pre="microbiota [ 164], such as IBD [ 165, 166, 167]," exact="cancer" post="[ 168], liver disease [ 169, 170] and recurrent"/>
  <result pre="such as IBD [ 165, 166, 167], cancer [ 168]," exact="liver disease" post="[ 169, 170] and recurrent C. difficile infection (CDI)"/>
  <result pre="microbial dehydroxylation of bile, and has been shown to promote" exact="liver cancer" post="in mice [ 185], and inhibit the growth of"/>
  <result pre="dehydroxylation of bile, and has been shown to promote liver" exact="cancer" post="in mice [ 185], and inhibit the growth of"/>
  <result pre="in the world. A recent study reported no evidence of" exact="cardiovascular disease" post="risk factors in this population [ 188] and older"/>
  <result pre="viral infections have also been associated with low-diversity dysbiosis, including" exact="hepatitis" post="C [ 204] and HIV [ 205]. While the"/>
  <result pre="enables contact between epithelial cells and bacteria resulting in spontaneous" exact="colitis" post="in mice [ 211], a feature shared with sufferers"/>
  <result pre="in mice [ 211], a feature shared with sufferers of" exact="ulcerative colitis" post="[ 212]. But a direct connection between dietary fibre"/>
  <result pre="mice [ 211], a feature shared with sufferers of ulcerative" exact="colitis" post="[ 212]. But a direct connection between dietary fibre"/>
  <result pre="are disrupted and examples include obesity, type 2 diabetes and" exact="metabolic syndrome," post="all of which are risk factors for cardiovascular disease."/>
  <result pre="and metabolic syndrome, all of which are risk factors for" exact="cardiovascular disease." post="Obesity and overweight are described as abnormal or excessive"/>
  <result pre="negatively impacts health [ 216] and according to the WHO," exact="obesity" post="has tripled since 1975. Indeed, in 2016, 39% of"/>
  <result pre="associated with insulin resistance and is a risk factor for" exact="cardiovascular disease" post="in diabetic individuals [ 218, 220]. Metabolic syndrome describes"/>
  <result pre="metabolism of glucose and lipids and is characterised by abdominal" exact="obesity" post="along with two or more of the following factors:"/>
  <result pre="also a risk factor for type 2 diabetes along with" exact="cardiovascular disease" post="[ 221]. The association between the gut microbiota and"/>
  <result pre="in mice. Indeed, germ free mice are protected against the" exact="obesity" post="that usually develops after consuming a Western-style, high fat,"/>
  <result pre="changes in the small intestine which preceded weight gain and" exact="obesity" post="and also showed significant associations with obesity progression and"/>
  <result pre="weight gain and obesity and also showed significant associations with" exact="obesity" post="progression and development of insulin resistance [ 225]. In"/>
  <result pre="between the gut microbiota and low-grade inflammation, a hallmark of" exact="obesity" post="which plays a major role in atherosclerotic cardiovascular disease"/>
  <result pre="hallmark of obesity which plays a major role in atherosclerotic" exact="cardiovascular disease" post="in humans [ 234]. Fourteen, mostly observational studies were"/>
  <result pre="axis&quot; may be involved in the very early stages of" exact="cardiovascular disease." post="These studies clearly illustrate the link between the gut"/>
  <result pre="lipid phosphatidylcholine have been identified as a risk factor for" exact="cardiovascular disease" post="in humans [ 245]. In the same study, dietary"/>
  <result pre="of mice with TMAO or choline was found to promote" exact="atherosclerosis" post="and studies with germ free mice indicated the significance"/>
  <result pre="for the link between dietary red meat ingestion and accelerated" exact="atherosclerosis" post="[ 241]. Interestingly, in the same study dietary supplementation"/>
  <result pre="Bifidobacteriaceae, and Fusobacteriaceae [ 256]. However, in patients suffering from" exact="chronic kidney disease," post="excretion is impaired. Chronic kidney disease and cardiovascular disease"/>
  <result pre="chronic kidney disease, excretion is impaired. Chronic kidney disease and" exact="cardiovascular disease" post="are closely associated and risk of death from cardiovascular"/>
  <result pre="cardiovascular disease are closely associated and risk of death from" exact="cardiovascular disease" post="is much higher in patients with end-stage renal disease"/>
  <result pre="suggesting it may contribute to hypertension and cardiovascular mortality in" exact="chronic kidney disease" post="[ 263]. In nephrectomised mice, it promoted cardiac apoptosis"/>
  <result pre="265] showed that intestinal uptake of p-cresol in patients with" exact="chronic kidney disease" post="associated with cardiovascular disease independent of renal function. Indoxyl"/>
  <result pre="of p-cresol in patients with chronic kidney disease associated with" exact="cardiovascular disease" post="independent of renal function. Indoxyl sulfate is another uremic"/>
  <result pre="uremic toxin. Like p-cresol, serum indoxyl sulfate is problematic for" exact="chronic kidney disease" post="patients. Barreto et al. [ 267] reported that baseline"/>
  <result pre="renal function and a direct relationship with aortic calcification in" exact="chronic kidney disease" post="patients. While the causative relationship between indoxyl sulfate and"/>
  <result pre="the causative relationship between indoxyl sulfate and the pathology of" exact="cardiovascular disease" post="has not yet been proven, studies to date suggest"/>
  <result pre="signalling pathways which have been implicated in different forms of" exact="cardiovascular disease" post="pathophysiologies, including coronary calcification, atherosclerotic vascular disease, arrhythmia, and"/>
  <result pre="shown to be a strong and independent risk factor for" exact="cardiovascular disease" post="and mortality in chronic kidney disease patients [ 270]."/>
  <result pre="and independent risk factor for cardiovascular disease and mortality in" exact="chronic kidney disease" post="patients [ 270]. The branched chain amino acids (BCAAs),"/>
  <result pre="‘diet-derived’ microbial metabolites, a recent study linking microbial BCAAs to" exact="glucose intolerance" post="and insulin resistance renders them worthy of mention. Indeed,"/>
  <result pre="increased circulating levels of BCAAs, induced insulin resistance and aggravated" exact="glucose intolerance." post="The authors state that further studies are required to"/>
  <result pre="result of overnutrition of protein which leads to insulin resistance," exact="glucose intolerance" post="and eventually type 2 diabetes. A systematic review of"/>
  <result pre="bestows protective effects against several diseases, including obesity, diabetes, hypertension," exact="cardiovascular disease," post="stroke, numerous cancers, allergic diseases, as well as Parkinson’s"/>
  <result pre="platelet aggregation, modulation of growth factors and hormones involved in" exact="cancer" post="pathogenesis, inhibition of nutrient sensing pathways by specific amino"/>
  <result pre="were not observed for non-obese individuals or obese individuals without" exact="metabolic syndrome." post="De Filippis et al. [ 284] reported that adherence"/>
  <result pre="with a greater frequency of pain in paediatric patients with" exact="irritable bowel syndrome" post="[ 297], has been found in patients with major"/>
  <result pre="bowel syndrome [ 297], has been found in patients with" exact="major depressive disorder" post="[ 298] and has been associated with type 2"/>
  <result pre="associated with a pro-inflammatory immune response and increased incidence of" exact="colitis" post="in genetically susceptible mice, but not wild type mice"/>
  <result pre="owing to microbial metabolic pathways. In humans at risk of" exact="metabolic syndrome," post="a high saturated fat diet, a high MUFA diet"/>
  <result pre="diet [ 315]. The transgenic mice were protected from obesity," exact="glucose intolerance" post="and hepatic steatosis and maintained a normal gut barrier"/>
  <result pre="to the gut microbiota were involved in the prevention of" exact="metabolic syndrome" post="in the transgenic mice. Trans fats contain unsaturated fatty"/>
  <result pre="consumption is associated with increased risk of disease, such as" exact="cardiovascular disease" post="[ 303], type 2 diabetes [ 317], and Alzheimer’s"/>
  <result pre="from animal models and cell lines, including protection against cancer," exact="obesity" post="and atherosclerosis, as well as immunomodulation which has been"/>
  <result pre="families Lachnospiraceae and Desulfovibrionaceae. Porphyromonadaceae has been associated with non-alcoholic" exact="fatty liver disease" post="(NAFLD) in mice [ 323], a manifestation of metabolic"/>
  <result pre="Lachnospiraceae and Desulfovibrionaceae. Porphyromonadaceae has been associated with non-alcoholic fatty" exact="liver disease" post="(NAFLD) in mice [ 323], a manifestation of metabolic"/>
  <result pre="liver disease (NAFLD) in mice [ 323], a manifestation of" exact="metabolic syndrome" post="in the liver [ 324]. The family has also"/>
  <result pre="The family has also been associated with cognitive impairment in" exact="cirrhosis" post="patients, whereas Lachnospiraceae abundance was reported to be lower"/>
  <result pre="patients, whereas Lachnospiraceae abundance was reported to be lower in" exact="cirrhosis" post="patients [ 325]. Lachnospiraceae has also been shown to"/>
  <result pre="recently has been suggested to play a protective role against" exact="colorectal cancer" post="[ 327]. Desulfovibrionaceae contains the sulfite-reducing species Bil. Wadsworthia."/>
  <result pre="has been suggested to play a protective role against colorectal" exact="cancer" post="[ 327]. Desulfovibrionaceae contains the sulfite-reducing species Bil. Wadsworthia."/>
  <result pre="also been associated with impaired glucose tolerance and most serious" exact="metabolic syndrome" post="phenotypes in mice [ 328]. Thus, the results of"/>
  <result pre="of GLP-1. Likewise, tartary buckwheat protein proved capable of preventing" exact="dyslipidemia" post="in mice fed a high fat diet which was"/>
  <result pre="reduce serum uremic toxin levels, including p-cresol sulfate, in non-dialysis," exact="chronic kidney disease" post="patients [ 362]. DGGE indicated a change in the"/>
  <result pre="383] reported that a high fructose diet induced markers of" exact="metabolic syndrome," post="inflammation and oxidative stress in rats, but these were"/>
  <result pre="transplant, the results suggest a correlation between their abundance and" exact="metabolic syndrome." post="8. Conclusions The link between nutrition, the gut microbiota"/>
  <result pre="this has been an alarming surge in non-communicable diseases, including" exact="cancer" post="and metabolic-related diseases. Understanding the specific role of the"/>
  <result pre="Adolph T.E. Gerner R.R. Moschen A.R. The intestinal microbiota in" exact="colorectal cancer" post="Cancer Cell 2018 33 954 964 10.1016/j.ccell.2018.03.004 29657127 7."/>
  <result pre="T.E. Gerner R.R. Moschen A.R. The intestinal microbiota in colorectal" exact="cancer" post="Cancer Cell 2018 33 954 964 10.1016/j.ccell.2018.03.004 29657127 7."/>
  <result pre="dietary fibre induction of proliferarion and apoptosis via butyrate for" exact="cancer" post="prevention Clin. Cancer Res. 2014 20 799 803 10.1158/1078-0432.CCR-13-2483"/>
  <result pre="Y. Ai L. Butyrate production from high-fibre diet protects against" exact="lymphoma" post="tumor Leuk. Lymphoma 2016 57 2401 2408 10.3109/10428194.2016.1144879 26885564"/>
  <result pre="Feron O. Muccioli G.G. et al. Gut microbiota-derived propionate reduces" exact="cancer" post="cell proliferation in the liver Br. J. Cancer 2012"/>
  <result pre="A.L. Shulman G.I. Acetate mediates a microbiome-brain-β-cell axis to promote" exact="metabolic syndrome" post="Nature 2016 534 213 217 10.1038/nature18309 27279214 98. LeBlanc"/>
  <result pre="Jegou S. Hoffmann T.W. Natividad J.M. et al. CARD9 impacts" exact="colitis" post="by altering gut microbiota metabolism of tryptophan into aryl"/>
  <result pre="Wilson K.H. Perini F. Role of competition for nutrients in" exact="suppression" post="of Clostridium difficile by the colonic microflora Infect. Immun."/>
  <result pre="of the colonic mucus barrier in a mouse model of" exact="colitis" post="Am. J. Physiol. Liver Physiol. 2011 300 G327 G333"/>
  <result pre="mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced" exact="colitis" post="Infect. Immun. 2011 79 1536 1545 10.1128/IAI.01104-10 21321077 160."/>
  <result pre="Hayes R.B. Yang L. Human gut microbiome and risk for" exact="colorectal cancer" post="J. Natl. Cancer Inst. 2013 105 1907 1911 10.1093/jnci/djt300"/>
  <result pre="R.B. Yang L. Human gut microbiome and risk for colorectal" exact="cancer" post="J. Natl. Cancer Inst. 2013 105 1907 1911 10.1093/jnci/djt300"/>
  <result pre="et al. Alterations of the human gut microbiome in liver" exact="cirrhosis" post="Nature 2014 513 59 64 10.1038/nature13568 25079328 170. Bajaj"/>
  <result pre="al. Altered profile of human gut microbiome is associated with" exact="cirrhosis" post="and its complications J. Hepatol. 2014 60 940 947"/>
  <result pre="Decreased diversity of the faecal microbiome in recurrent Clostridium difficile–associated" exact="diarrhea" post="J. Infect. Dis. 2008 197 435 438 10.1086/525047 18199029"/>
  <result pre="H. Hattori M. et al. Obesity-induced gut microbial metabolite promotes" exact="liver cancer" post="through senescence secretome Nature 2013 499 97 101 10.1038/nature12347"/>
  <result pre="Hattori M. et al. Obesity-induced gut microbial metabolite promotes liver" exact="cancer" post="through senescence secretome Nature 2013 499 97 101 10.1038/nature12347"/>
  <result pre="B. Chang E.B. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and" exact="colitis" post="in Il10 −/− mice Nature 2012 487 104 108"/>
  <result pre="Sancilio A. Wood B.M. Physical activity patterns and biomarkers of" exact="cardiovascular disease" post="risk in hunter-gatherers Am. J. Hum. Biol. 2017 29"/>
  <result pre="analysis of the microbiota of children suffering from acute infectious" exact="diarrhea" post="and their recovery after treatment Front. Microbiol. 2018 9"/>
  <result pre="Fujiwara K. Yoneda M. et al. Gut dysbiosis associated with" exact="hepatitis" post="C infection Clin. Infect. Dis. 2018 10.1093/cid/ciy205 205. Nowak"/>
  <result pre="A. Öhman L. Strid H. Sjövall H. et al. Spontaneous" exact="colitis" post="in Muc2-deficient mice reflects clinical and cellular features of"/>
  <result pre="in Muc2-deficient mice reflects clinical and cellular features of active" exact="ulcerative colitis" post="PLoS ONE 2014 9 e100217 10.1371/journal.pone.0100217 24945909 212. Johansson"/>
  <result pre="Muc2-deficient mice reflects clinical and cellular features of active ulcerative" exact="colitis" post="PLoS ONE 2014 9 e100217 10.1371/journal.pone.0100217 24945909 212. Johansson"/>
  <result pre="normally impenetrable inner colon mucus layer in both murine and" exact="colitis" post="models and patients with ulcerative colitis Gut 2014 63"/>
  <result pre="layer in both murine and colitis models and patients with" exact="ulcerative colitis" post="Gut 2014 63 281 289 10.1136/gutjnl-2012-303207 23426893 213. Desai"/>
  <result pre="in both murine and colitis models and patients with ulcerative" exact="colitis" post="Gut 2014 63 281 289 10.1136/gutjnl-2012-303207 23426893 213. Desai"/>
  <result pre="10 December 2018) 220. Mooradian A.D. Dyslipidemia in type 2" exact="diabetes mellitus" post="Nat. Rev. Endocrinol. 2009 5 150 159 10.1038/ncpendmet1066 19229235"/>
  <result pre="F. Yannakoulia M. Chan J.L. Mantzoros C.S. Management of the" exact="metabolic syndrome" post="and type 2 diabetes through lifestyle modification Annu. Nutr."/>
  <result pre="Semenkovich C.F. Gordon J.I. Mechanisms underlying the resistance to diet-induced" exact="obesity" post="in germ-free mice Proc. Natl. Acad. Sci. USA 2007"/>
  <result pre="Bacteria interactions promote intestinal inflammation which precedes and correlates with" exact="obesity" post="and insulin resistance in mouse PLoS ONE 2010 5"/>
  <result pre="S. Gordon J.I. Microbial ecology: Human gut microbes associated with" exact="obesity" post="Nature 2006 444 1022 1023 10.1038/4441022a 17183309 229. Turnbaugh"/>
  <result pre="M.C.G. Higher level of faecal SCFA in women correlates with" exact="metabolic syndrome" post="risk factors Br. J. Nutr. 2013 109 914 919"/>
  <result pre="microbiota metabolism of L-carnitine, a nutrient in red meat, promotes" exact="atherosclerosis" post="Nat. Med. 2013 19 576 585 10.1038/nm.3145 23563705 242."/>
  <result pre="Chung Y.M. et al. Gut flora metabolism of phosphotidylcholine promotes" exact="cardiovascular disease" post="Nature 2011 472 57 63 10.1038/nature09922 21475195 246. Kühn"/>
  <result pre="Qi L. Gut microbiota metabolites and risk of major adverse" exact="cardiovascular disease" post="events and death: A systematic review and meta analysis"/>
  <result pre="inhibition of gut microbial trimethylamine production for the treatment of" exact="atherosclerosis" post="Cell 2015 163 1585 1595 10.1016/j.cell.2015.11.055 26687352 255. Saito"/>
  <result pre="Chen S. Zhang P.-Y. Cardiovascular disease and its relationship with" exact="chronic kidney disease" post="Eur. Med. Pharmacol. Sci. 2014 18 2918 2926 260."/>
  <result pre="L. Zhang R. p-Cresyl sulfate aggravates cardiac dysfunction associated with" exact="chronic kidney disease" post="by enhancing apoptosis of cardiomyocytes J. Am. Heart Assoc."/>
  <result pre="disease relates to intestinal uptake of p-cresol in patients with" exact="chronic kidney disease" post="BMC Nephrol. 2014 15 87 10.1186/1471-2369-15-87 24912660 266. Li"/>
  <result pre="indoxyl sulfate is associated with vascular disease and mortality in" exact="chronic kidney disease" post="patients Clin. J. Am. Soc. Nephrol. 2009 4 1551"/>
  <result pre="Role of uremic toxin indoxyl sulphate in the progression of" exact="cardiovascular disease" post="Life Sci. 2017 185 23 29 10.1016/j.lfs.2017.07.027 28754616 269."/>
  <result pre="D. Meijers B. Microbiota-derived phenylacetylglutamine associates with overall mortality and" exact="cardiovascular disease" post="in patients with CKD J. Am. Soc. Nephrol. 2016"/>
  <result pre="A. et al. Gastrointestinal microbiome signatures of pediatric patients with" exact="irritable bowel syndrome" post="Gastroenterology 2011 141 1782 1791 10.1053/j.gastro.2011.06.072 21741921 298. Jiang"/>
  <result pre="J. et al. Altered faecal microbiota composition in patients with" exact="major depressive disorder" post="Brain Behav. Immun. 2015 48 186 194 10.1016/j.bbi.2015.03.016 25882912"/>
  <result pre="energy harvesting capacity of the gut microbiota: Relationship to diet," exact="obesity" post="and time in mouse models Gut 2010 59 1635"/>
  <result pre="28379213 303. Iqbal M.P. Trans fatty acids—A risk factor for" exact="cardiovascular disease" post="Pak. J. Med. Sci. 2014 30 194 197 10.12669/pjms.301.4525"/>
  <result pre="M. Müller M. van der Meer R. Saturated fat stimulates" exact="obesity" post="and hepatic steatosis and affects gut microbiota composition by"/>
  <result pre="murine gut associated with the development of dextran sodium sulfate-induced" exact="colitis" post="Inflamm. Bowel Dis. 2010 17 917 926 10.1002/ibd.21462 21391286"/>
  <result pre="and its correlation to physiological and biochemical parameters related to" exact="metabolic syndrome" post="PLoS ONE 2018 13 e0190368 10.1371/journal.pone.0190368 29293629 311. Kovatcheva-Datchary"/>
  <result pre="faecal microbiome and short chain fatty acid excretion in a" exact="metabolic syndrome" post="‘at-risk’ population Int. J. Obes. (Lond.) 2013 37 216"/>
  <result pre="PUFA–Altered Gut microbiota of FAT-1 mice to wild-type littermates prevents" exact="obesity" post="and associated metabolic disorders Diabetes 2018 67 1512 1523"/>
  <result pre="Ascherio A. Stampfer M.J. Willett W.C. Trans fatty acids and" exact="cardiovascular disease" post="N. Engl. J. Med. 2006 354 1601 1613 10.1056/NEJMra054035"/>
  <result pre="M.J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and" exact="obesity" post="Nature 2012 482 179 185 10.1038/nature10809 22297845 324. Rinella"/>
  <result pre="22297845 324. Rinella M. Charlton M. The globalization of non-alcoholic" exact="fatty liver disease" post="- Prevalence and impact on world health Hepatology 2016"/>
  <result pre="324. Rinella M. Charlton M. The globalization of non-alcoholic fatty" exact="liver disease" post="- Prevalence and impact on world health Hepatology 2016"/>
  <result pre="M. Gillevet P.M. Linkage of gut microbiome with cognition in" exact="hepatic encephalopathy" post="Am. J. Physiol. Gastrointest. Liver Physiol. 2011 302 G168"/>
  <result pre="Gillevet P.M. Linkage of gut microbiome with cognition in hepatic" exact="encephalopathy" post="Am. J. Physiol. Gastrointest. Liver Physiol. 2011 302 G168"/>
  <result pre="M. Shanahan F. O’ Toole P.W. The oral microbiota in" exact="colorectal cancer" post="is distinctive and predictive Gut 2018 67 1454 1463"/>
  <result pre="Shanahan F. O’ Toole P.W. The oral microbiota in colorectal" exact="cancer" post="is distinctive and predictive Gut 2018 67 1454 1463"/>
  <result pre="microbiota and low-grade systemic inflammation: Mechanisms and clinical implications on" exact="obesity" post="Int. J. Food Sci. Nutr. 2018 69 125 143"/>
  <result pre="330. Barañano K.W. Hartman A.L. The ketogenic diet: Uses in" exact="epilepsy" post="and other neurologic illnesses Options Neurol. 2008 10 410"/>
  <result pre="Tachibana N. et al. Dietary soybean protein ameliorates high-fat diet-induced" exact="obesity" post="by modifying the gut microbiota-dependent biotransformation of bile acids"/>
  <result pre="Xiao Y. Zhou Y.-M. Liu T.-Y. Tartary buckwheat protein prevented" exact="dyslipidemia" post="in high-fat diet-fed mice associated with gut microbiota changes"/>
  <result pre="S. Jones M. Bacterial bile metabolising gene abundance in Crohn’s," exact="ulcerative colitis" post="and type 2 diabetes metagenomes PLoS ONE 2014 9"/>
  <result pre="Jones M. Bacterial bile metabolising gene abundance in Crohn’s, ulcerative" exact="colitis" post="and type 2 diabetes metagenomes PLoS ONE 2014 9"/>
  <result pre="uremic toxin serum levels from the gut microbiota in nondialysis" exact="chronic kidney disease" post="patients? J. Ren. Nutr. 2018 28 208 214 10.1053/j.jrn.2017.11.007"/>
  <result pre="K. Diet-driven microbiota dysbiosis is associated with vagal remodeling and" exact="obesity" post="Physiol. Behav. 2017 173 305 317 10.1016/j.physbeh.2017.02.027 28249783 382."/>
  <result pre="A. Baccigalupi L. Ricca E. Iossa S. Rescue of fructose-induced" exact="metabolic syndrome" post="by antibiotics or faecal transplantation in a rat model"/>
  <result pre="by antibiotics or faecal transplantation in a rat model of" exact="obesity" post="PLoS ONE 2015 10 e0134893 10.1371/journal.pone.0134893 26244577 Figure 1"/>
 </snippets>
</snippetsTree>
